History and Evolution of Clinical Research Regulation in India – Recent Reforms and Current Landscape

Explore the evolution of Indian Regulation

Full briefing — the morning intelligence for investors and analysts:
https://burns-media.com/biotech/archive/2026-04-21?utm_source=mastodon&utm_medium=social&utm_campaign=biotech_daily

Free. Delivered by 7 AM ET, every weekday.

#Biotech #FDA #Pharma #ClinicalTrials

Eli Lilly's $3.25B Kelonia buyout expands cancer pipeline

Eli Lilly's acquisition of Kelonia Therapeutics for up to $3.25 billion signals a major investment in CAR-T therapies targeting multiple myeloma. This…

Burns Media

Clinical trial: An autologous and antigen-specific cell-based therapy of vitamin D3-treated and myelin-derived peptide loaded tolerogenic dendritic cells in subjects with progressive forms of multiple sclerosis: a phase IIa, open-label, self-controlled, multi-center clinical trial.

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2025-522040-40-01?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20463

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Search for clinical trials - EMA

The last day to submit a talk for Virtual R/Pharma 2026 is May 2nd!

First-time speakers are very welcome — we offer free coaching!

Submit here: https://sessionize.com/rpharma-2026/

Follow us: https://linkedin.com/company/open-source-in-pharma

#RStats #Python #Pharma #ClinicalTrials #AI #LLM

R/Pharma 2026: Call for Speakers

Biotech Catalyst Daily — FDA & Clinical Trial Intelligence

The catalyst calendar for investors allocating against FDA decisions.

Burns Media

Clinical trial: Investigation of the Relationship Between Serum GFAP, NfL, and VEGF Levels and Clinical Progression Markers in Progressive Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07535242?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20448

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Effects of Sleep Quality on Cognitive Flexibility, Physical Activity, Body Awareness, and Reaction Time in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07536503?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20449

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Search for clinical trials - EMA

These challenges directly impact timelines, costs, and study outcomes.

In our latest article, we break down:
✔ Key patient recruitment challenges
✔ Practical strategies to overcome them
✔ How CROs can accelerate enrollment and improve retention
#PatientRecruitment #ClinicalTrials #ClinicalResearch #CRO 
#ClinicalTrialRecruitment #PatientEnrollment #ClinicalOperations 
#PatientRetention #RecruitmentChallenges #ClinicalResearchIndia

https://genelifecr.blogspot.com/2026/04/patient-recruitment-challenges-in.html

Patient Recruitment Challenges in Clinical Trials and How to Overcome Them

learn about Genelife Clinical Research Smarter Patient Recruitment Through Disease Surveillance